EyePoint (EYPT) Operating Margin Growth (1y) (2011 - 2026)

EyePoint (EYPT) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,552.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -170.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -1.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.23 Mn
Dec 31, 2025 -1.10 Mn
Sep 30, 2025 -610,963.00
Jun 30, 2025 -80,230.00
Mar 31, 2025 8,547.00
Dec 31, 2024 -27,381.00
Sep 30, 2024 -21,646.00
Jun 30, 2024 -11,454.00
Mar 31, 2024 -464.00
Dec 31, 2023 29,864.00
Sep 30, 2023 8,905.00
Jun 30, 2023 -8,383.00
Mar 31, 2023 -8,381.00
Dec 31, 2022 -25,886.00
Sep 30, 2022 -1,472.00
Jun 30, 2022 -4,434.00
Mar 31, 2022 -4,741.00
Dec 31, 2021 2,226.00
Sep 30, 2021 -15,657.00
Jun 30, 2021 14,874.00